These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 17699437

  • 1. Therapeutic monitoring of calcineurin inhibitors for the nephrologist.
    Schiff J, Cole E, Cantarovich M.
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):374-84. PubMed ID: 17699437
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin inhibitors in heart transplantation.
    Keogh A.
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of calcineurin antagonists.
    Kapturczak MH, Meier-Kriesche HU, Kaplan B.
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitors in heart transplantation.
    Crespo-Leiro MG.
    Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 6. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ, Garbade J, Bittner HB, Fiedler M, Dhein S, Thiery J, Mohr FW, Gummert JF.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2011-7. PubMed ID: 17161355
    [Abstract] [Full Text] [Related]

  • 7. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients.
    Bucuvalas JC, Ryckman FC, Arya G, Andrew B, Lesko A, Cole CR, James B, Kotagal U.
    J Pediatr; 2005 Jun 20; 146(6):744-50. PubMed ID: 15973310
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G, Srinivas TR, Meier-Kriesche HU.
    Transpl Int; 2007 Oct 20; 20(10):813-27. PubMed ID: 17645419
    [Abstract] [Full Text] [Related]

  • 9. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV, Nash MM, McFarlane PA, Zaltzman JS.
    Nephron Clin Pract; 2004 Oct 20; 97(2):c35-40. PubMed ID: 15218328
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F, Lorf T, Schütz E, Christians U, Grupp C, Sattler B, Canelo R, Sewing KF, Armstrong VW, Oellerich M, Ringe B.
    Transplant Proc; 1996 Dec 20; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract] [Full Text] [Related]

  • 11. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr 20; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

  • 12. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T, Aisa Y, Kato J, Nakamura Y, Ikeda Y, Okamoto S.
    Bone Marrow Transplant; 2009 Sep 20; 44(6):371-4. PubMed ID: 19270729
    [Abstract] [Full Text] [Related]

  • 13. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L.
    G Ital Nefrol; 2008 Sep 20; 25(3):317-24. PubMed ID: 18473303
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB, Karamperis N, Jørgensen KA.
    Transplant Proc; 2005 May 20; 37(4):1736-8. PubMed ID: 15919449
    [Abstract] [Full Text] [Related]

  • 15. The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.
    Pilmore H, Caring for Australians with Renal Impairment (CARI).
    Nephrology (Carlton); 2007 Feb 20; 12 Suppl 1():S88-97. PubMed ID: 17316287
    [No Abstract] [Full Text] [Related]

  • 16. Statistical process control and calcineurin inhibitor management.
    Dunn SP.
    J Pediatr; 2005 Jun 20; 146(6):720-1. PubMed ID: 15973304
    [No Abstract] [Full Text] [Related]

  • 17. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.
    Sommerer C, Giese T, Meuer S, Zeier M.
    Saudi J Kidney Dis Transpl; 2010 Nov 20; 21(6):1030-7. PubMed ID: 21060169
    [Abstract] [Full Text] [Related]

  • 18. The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.
    McTaggart S, Caring for Australians with Renal Impairment (CARI).
    Nephrology (Carlton); 2007 Feb 20; 12 Suppl 1():S106-10. PubMed ID: 17316270
    [No Abstract] [Full Text] [Related]

  • 19. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L.
    Transpl Immunol; 2009 Jan 20; 20(3):139-42. PubMed ID: 18834941
    [Abstract] [Full Text] [Related]

  • 20. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan 20; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.